Acute effects of dietary fat on inflammatory markers and gene expression in first-degree relatives of type 2 diabetes patients

Review of Diabetic Studies

Volumn 8, Issue 4, 2011, Pages 477-489

  Pietraszek, Anna ^a   Gregersen, Søren ^a   Hermansen, Kjeld ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Dietary fat; Fat rich meal; Gene expression; Genetic predisposition; Interleukin 6; Postprandial inflammation; Postprandial period; Type 2 diabetes

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; MEDIUM CHAIN FATTY ACID; MONOUNSATURATED FATTY ACID;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; DIABETIC PATIENT; FAT INTAKE; FEMALE; GENE EXPRESSION; HUMAN; INFLAMMATION; MALE; MUSCLE BIOPSY; MUSCLE TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RELATIVE; TEST MEAL;

EID: 84862486277     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2011.8.477     Document Type: Article

References (41)

1. Saydah SH, Eberhardt MS, Loria CM, Brancati FL. Age and the burden of death attributable to diabetes in the United States. Am J Epidemiol 2002. 156:714-719.
2. Sarlund H. Coronary heart disease and its risk factors in first-degree relatives of non-insulin-dependent diabetic and non-diabetic subjects. Publication of the University of Kuopio 1987, original report 6.
3. Mortensen LS, Thomsen C, Hermansen K. Effects of different protein sources on plasminogen inhibitor-1 and factor VII coagulant activity added to a fat-rich meal in type 2 diabetes. Rev Diabet Stud 2010. 7:233-240.
4. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, Danesh J, Tipping RW, Ford CE, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010. 375:132-140.
5. Saltevo J, Kautiainen H, Vanhala M. Gender differences in adiponectin and low-grade inflammation among individuals with normal glucose tolerance, prediabetes, and type 2 diabetes. Gend Med 2009. 6:463-470.
6. Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin - the classical, resistin - the controversical, adiponectin - the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005. 19:525-546.
7. Galland L. Diet and inflammation. Nutr Clin Pract 2010. 25:634-640.
8. Ceriello A, Assaloni R, Da Ros R, Maier A, Piconi L, Quagliaro L, Esposito K, Giugliano G. Effect of ator-vastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. Circulation 2005. 111:2518-2524.
9. Blum S, Aviram M, Ben-Amotz A, Levy Y. Effect of a Mediterranean meal on postprandial carotenoids, paraoxonase activity and C-reactive protein levels. Ann Nutr Metab 2006. 50:20-24.
10. Rubin D, Helwig U, Nothnagel M, Lemke N, Schreiber S, Folsch UR, Doring F, Schrezenmeir J. Postprandial plasma adiponectin decreases after glucose and high fat meal and is independently associated with postprandial triacylglycerols but not with -- 11388 promoter polymorphism. Br J Nutr 2008. 99:76-82.
11. Esposito K, Nappo F, Giugliano F, Di Palo C, Ciotola M, Barbieri M, Paolisso G, Giugliano D. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 2003. 78:1135-1140.
12. Raben A, Agerholm-Larsen L, Flint A, Holst JJ, As-trup A. Meals with similar energy densities but rich in protein, fat, carbohydrate, or alcohol have different effects on energy expenditure and substrate metabolism but not on appetite and energy intake. Am J Clin Nutr 2003. 77:91-100.
13. Romon M, Lebel P, Velly C, Marecaux N, Fruchart JC, Dallongeville J. Leptin response to carbohydrate or fat meal and association with subsequent satiety and energy intake. Am J Physiol 1999. 277:E855-E861.
14. Poppitt SD, Keogh GF, Lithander FE, Wang Y, Mul-vey TB, Chan YK, McArdle BH, Cooper GJ. Postprandial response of adiponectin, interleukin-6, tumor necrosis factor-alpha, and C-reactive protein to a high-fat dietary load. Nutrition 2008. 24:322-329.
15. Nappo F, Esposito K, Cioffi M, Giugliano G, Moli-nari AM, Paolisso G, Marfella R, Giugliano D. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol 2002. 39:1145-1150.
16. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001. 29(9):E45.
17. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995. 57:289-300.
18. Calabrese C, Myer S, Munson S, Turet P, Birdsall TC. A cross-over study of the effect of a single oral feeding of medium chain triglyceride oil vs. canola oil on post-ingestion plasma triglyceride levels in healthy men. Altern Med Rev 1999. 4:23-28.
19. Badawi A, Klip A, Haddad P, Cole DE, Bailo BG, El-Sohemy A, Karmali M. Type 2 diabetes mellitus and inflammation: prospects for biomarkers of risk and nutritional intervention. Diabetes Metab Syndr Obes 2010. 3:173-186.
20. Guzzardi MA, Iozzo P. Fatty heart, cardiac damage, and inflammation. Rev Diabet Stud 2011. 8(3):403-417.
21. Dekker MJ, Wright AJ, Mazurak VC, Marangoni AG, Rush JW, Graham TE, Robinson LE. Fasting triacyl-glycerol status, but not polyunsaturated/saturated fatty acid ratio, influences the postprandial response to a series of oral fat tolerance tests. J Nutr Biochem 2009. 20:694-704.
22. Schlitt A, Schwaab B, Fingscheidt K, Lackner KJ, Heine GH, Vogt A, Buerke M, Maegdefessel L, Raaz U, Werdan K, et al. Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes. Lipids 2010. 45:129-135.
23. Hojbjerre L, Sonne MP, Alibegovic AC, Nielsen NB, Dela F, Vaag A, Bruun JM, Staalknecht B. Impact of physical inactivity on adipose tissue low-grade inflammation in first-degree relatives of type 2 diabetic patients. Diabetes Care 2011. 34:2265-2272.
24. Tesauro M, Rizza S, Iantorno M, Campia U, Cardillo C, Lauro D, Leo R, Turriziani M, Cocciolillo GC, Fusco A, et al. Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus. Metabolism 2007. 56:413-419.
25. Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, Campbell LV. Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care 2004. 27:2033-2040.
26. Ford ES, Giles WH, Mokdad AH. Family history of diabetes or cardiovascular disease and C-reactive protein concentration: findings from the National Health and Nutrition Examination Survey, 1999-2000. Am J Prev Med 2005. 29:57-62.
27. Carey AL, Febbraio MA. Interleukin-6 and insulin sensitivity: friend or foe? Diabetologia 2004. 47:1135-1142.
28. Pickup JC, Chusney GD, Thomas SM, Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cyto-kine production in type 2 diabetes. Life Sci 2000. 67:291-300.
29. Petersen KF, Dufour S, Befroy D, Garcia R, Shul-man GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004. 350:664-671.
30. Madec S, Corretti V, Santini E, Ferrannini E, Solini A. Effect of a fatty meal on inflammatory markers in healthy volunteers with a family history of type 2 diabetes. Br J Nutr 2011. 106:364-368.
31. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003. 278:45777-45784.
32. Jimenez-Gomez Y, Lopez-Miranda J, Blanco-Colio LM, Marin C, Perez-Martinez P, Ruano J, Paniagua JA, Rodriguez F, Egido J, Perez-Jimenez F. Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men. Atherosclerosis 2009. 204:E70-E76.
33. Salmenniemi U, Zacharova J, Ruotsalainen E, Vauhkonen I, Pihlajamaki J, Kainulainen S, Pun-nonen K, Laakso M. Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients. J Clin Endocrinol Metab 2005. 90:4216-4223.
34. Kowalska I, Straczkowski M, Nikolajuk A, Kru-kowska A, Kinalska I, Gorska M. Plasma adiponectin concentration and tumor necrosis factor-alpha system activity in lean non-diabetic offspring of type 2 diabetic subjects. Eur J Endocrinol 2006. 154:319-324.
35. Moran CN, Barwell ND, Malkova D, Cleland SJ, McPhee I, Packard CJ, Zammit VA, Gill JM. Effects of diabetes family history and exercise training on the expression of adiponectin and leptin and their receptors. Metabolism 2011. 60:206-214.
36. Peake PW, Kriketos AD, Denyer GS, Campbell LV, Charlesworth JA. The postprandial response of adi-ponectin to a high-fat meal in normal and insulin-resistant subjects. Int J Obes Relat Metab Disord 2003. 27:657-662.
37. Iraklianou S, Melidonis A, Tournis S, Konstandelou E, Tsatsoulis A, Elissaf M, Sideris D. Postprandial leptin responses after an oral fat tolerance test: differences in type 2 diabetes. Diabetes Care 2001. 24:1299-1301.
38. Paniagua JA, de la Sacristana AG, Romero I, Vidal-Puig A, Latre JM, Sanchez E, Perez-Martinez P, Lopez-Miranda J, Perez-Jimenez F. Monounsatu-rated fat-rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate-rich diet in insulin-resistant subjects. Diabetes Care 2007. 30:1717-1723.
39. Hotamisligil GS. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999. 245:621-625.
40. Hyson DA, Paglieroni TG, Wun T, Rutledge JC. Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men. Clin Appl Thromb Hemost 2002. 8:147-155.
41. Sell H, Eckel J. Monocyte chemotactic protein-1 and its role in insulin resistance. Curr Opin Lipidol 2007. 18:258-262.